WebDoctor Encyclopedia

Article

Radioactive Iodine Therapy (I-131)

What is radioactive iodine therapy?

Radioactive iodine therapy (often called RAI or I-131 therapy) is a treatment in which you swallow a capsule or drink containing a radioactive form of iodine, called iodine-131. It is used mainly after surgery for the most common types of thyroid cancer, and also for some non-cancerous overactive thyroid conditions.

The treatment works because thyroid cells are the only cells in the body that actively collect iodine in large amounts. They need iodine to make thyroid hormone. When radioactive iodine is swallowed, it travels in the blood and is taken up by any remaining thyroid tissue and by thyroid cancer cells that still behave like normal thyroid cells. The radiation then destroys those cells from the inside.

This makes radioactive iodine one of the earliest and best examples of a targeted cancer treatment. It has been used for over 80 years, and it allows a whole-body treatment with relatively few side effects in other organs.

The three aims of treatment

Aim What it means
Remnant ablation Destroys small amounts of normal thyroid tissue left after surgery, making follow-up blood tests and scans easier to read
Adjuvant treatment Treats possible microscopic cancer cells left behind, to lower the risk of the cancer coming back
Treatment of known disease Treats cancer that remains in the neck or has spread, for example to the lungs or bones

1. Key facts at a glance

Feature Details
Type of treatment Radionuclide (internal) therapy
Main use Differentiated thyroid cancer after total thyroidectomy
How it is given Swallowed as a capsule or liquid
Preparation Low-iodine diet and either TSH injections or stopping thyroid hormone tablets
Hospital stay Often 1-3 nights in a shielded room; sometimes outpatient for low doses
Radiation precautions Distance from others for several days after treatment
Course length Usually a single dose; repeated treatment only if needed
Main side effects Neck tenderness, dry mouth, taste changes, swollen salivary glands, nausea

2. How it works

Step What happens in the body
1. TSH is raised High levels of thyroid-stimulating hormone (TSH) make thyroid cells hungry for iodine
2. Iodine is low A low-iodine diet beforehand empties the body’s iodine stores
3. I-131 is swallowed It is absorbed from the stomach into the blood
4. Uptake Thyroid cells and differentiated cancer cells pull the radioactive iodine inside
5. Beta radiation Short-range particles damage the cells from within, travelling only around 1-2 mm
6. Clearance Iodine not taken up is removed in urine, sweat and saliva over several days

I-131 also gives off gamma rays, which travel further. These allow doctors to take a whole-body scan after treatment to show where the iodine has gone. They are also the reason for the safety precautions around other people.

Raising TSH

Method How it works Pros and cons
Recombinant human TSH injections Two injections on the two days before treatment You keep taking thyroid hormone tablets and avoid symptoms of an underactive thyroid
Thyroid hormone withdrawal Tablets are stopped for around 3-4 weeks Can cause tiredness, low mood and feeling cold; still used in some situations

The ESTIMABL1 trial found that these two methods worked equally well in low-risk thyroid cancer, as did a lower and a higher activity of I-131 (Schlumberger et al., 2018).

3. Who it is for

Conditions treated

Condition Role of radioactive iodine
Papillary thyroid carcinoma Used after surgery for intermediate and high-risk disease; often not needed for low-risk cancer
Follicular thyroid carcinoma Used after surgery, particularly when there is invasion of blood vessels or spread
Oncocytic (Hurthle cell) thyroid carcinoma Used in selected cases, although these tumours often take up less iodine
Poorly differentiated thyroid carcinoma Used when the tumour still takes up iodine
Malignant struma ovarii Thyroid-type cancer in the ovary; may be treated with surgery and radioactive iodine

Cancers it does not treat

Condition Why not
Medullary thyroid carcinoma Arises from C cells, which do not take up iodine
Anaplastic thyroid carcinoma Has lost the ability to absorb iodine
Primary thyroid lymphoma A blood cell cancer that is treated in other ways

Choosing whether RAI is needed

Doctors use risk groups based on tumour size, spread to lymph nodes, invasion beyond the thyroid and other features. A review of thyroid cancer notes that radioactive iodine after surgery improves survival for people at high risk of recurrence (Boucai et al., 2024).

Risk group Typical recommendation
Low risk Often no radioactive iodine; follow-up with blood tests and ultrasound
Intermediate risk Decided case by case
High risk Usually recommended
Known spread to lungs or bones Used as treatment, sometimes repeatedly

4. Before treatment

Step Details
Total thyroidectomy Most of the thyroid must be removed for RAI to work well
Low-iodine diet Usually for 1-2 weeks; avoid iodised salt, seafood, seaweed, dairy and some food colourings
Avoid iodine contrast CT scans with iodine contrast can block treatment for weeks
TSH preparation Injections or stopping tablets as planned
Pregnancy test Pregnancy must be excluded; breastfeeding must stop well before treatment
Planning at home Arrange care for children and pets during the precaution period

Coping with the low-iodine diet

The diet can feel restrictive, but it is short. Fresh meat, fresh vegetables, fruit, rice, pasta and home-cooked food with non-iodised salt are usually allowed. Many thyroid cancer charities publish recipe ideas. Planning meals for the whole family can make the weeks easier, and your team or a dietitian can answer questions about specific foods.

5. What to expect: step by step

Step What happens
1. Admission You are admitted to a single room with its own bathroom, often with lead shielding
2. Swallowing the dose You swallow a capsule or drink in front of a specialist
3. First hours You stay in the room; staff visits are short and kept to a minimum
4. Drinking and passing urine You are encouraged to drink plenty and empty your bladder often to clear unused iodine
5. Sucking sweets Sour sweets or chewing gum may be advised to keep saliva flowing
6. Radiation checks Staff measure radiation levels each day
7. Discharge You go home once levels are low enough, usually after 1-3 days
8. Post-therapy scan A whole-body scan is done a few days after treatment
9. Restart tablets If you stopped thyroid hormone, you restart it as directed

Precautions at home

Precaution Typical duration
Sleep alone Several days
Keep a distance from children and pregnant women Several days to about a week, depending on the dose
Use separate towels and cutlery; flush twice Several days
Avoid public transport for long journeys A few days
Avoid pregnancy At least 6 months
Avoid fathering a child Usually several months

The exact advice depends on the dose and on local rules, so follow the written instructions given by your team.

6. Side effects and risks

Side effect When it occurs Notes
Neck pain or swelling First few days Thyroid remnant reacting to the radiation
Nausea First day or two Anti-sickness medicine can help
Swollen, tender salivary glands Days to weeks Salivary glands also take up some iodine
Dry mouth Weeks to permanent More likely with higher or repeated doses
Taste changes Weeks Usually temporary
Watery or dry eyes Months From effects on the tear ducts
Temporary drop in blood counts Weeks Usually mild
Lower fertility Mostly temporary More likely with repeated high doses
Second cancer Years later, rare A small risk with high cumulative doses

7. Results and outlook

Study Main finding
ESTIMABL1 (752 adults, low-risk thyroid cancer) After five years, 98% had no evidence of disease, regardless of the activity used or the way TSH was raised (Schlumberger et al., 2018)
ESTIMABL2 (776 adults, low-risk thyroid cancer) At five years, outcomes with no radioactive iodine were not worse than outcomes with it: 93.2% versus 94.8% had no events (Leboulleux et al., 2025)
Review of thyroid cancer Five-year relative survival for thyroid cancer overall is about 98.5% (Boucai et al., 2024)

These trials have led to less radioactive iodine being used for low-risk thyroid cancer, and to lower doses when it is used. A review of radioactive iodine therapy describes a move towards tailoring the dose to each person’s risk (Ciarallo and Rivera, 2020).

When cancer stops absorbing iodine

Some thyroid cancers lose the ability to take up iodine, especially in advanced disease. These are called radioiodine-refractory cancers. They are treated with other approaches, such as surgery, external radiotherapy, multikinase inhibitors or targeted drugs matched to gene changes such as BRAF, RET or NTRK (Boucai et al., 2024).

8. Recovery and aftercare

Period What to expect
First week Follow radiation precautions; manage nausea and neck discomfort
Weeks 1-4 Salivary or taste changes may appear and usually settle
6-12 months Thyroglobulin blood test and neck ultrasound to check the response
Long term Lifelong thyroid hormone tablets and regular follow-up

Thyroid hormone tablets

After total thyroidectomy, you will need levothyroxine for life. The dose is adjusted using blood tests. In higher-risk cancers, the dose may be set to keep TSH low to reduce the chance of recurrence.

Protecting your salivary glands

  • Drink plenty of water in the days after treatment
  • Massage the glands in front of the ears and under the jaw if advised
  • Keep up dental care, as a dry mouth increases the risk of tooth decay
  • Tell your team if swelling or pain does not settle

Feeling isolated

Spending a few days in a shielded room and then keeping a distance from loved ones can feel lonely. Bring a phone, laptop, books or films, and plan video calls with family. Items you bring may need to be checked for radiation before they leave the room, so choose things you do not mind leaving behind for a while.

9. Alternatives

Alternative When it is considered
Surgery and follow-up without RAI Low-risk thyroid cancer
Active surveillance Very small papillary cancers in selected people
Further neck surgery Recurrent cancer in the neck
External beam radiotherapy Disease that does not take up iodine, or cannot be removed
Multikinase inhibitors Advanced radioiodine-refractory cancer
Targeted therapy Cancers with specific gene changes

Life after treatment

Most people return to work and normal life within a week or two of treatment. Thyroid cancer generally has an excellent outlook, and many people treated with radioactive iodine go on to live without any sign of cancer. Regular follow-up visits help catch any recurrence early, when it is easiest to treat.

10. Frequently asked questions

Question Answer
Will I lose my hair? No; hair loss is not a typical side effect
Can I be near my family? Yes, after a short period of precautions
Will I need more than one treatment? Most people need only one
Can I have children afterwards? Yes, after waiting the recommended time
Do I have to stay in hospital? Often for 1-3 nights, depending on the dose and local rules
Can I travel by plane afterwards? Yes, but carry your treatment letter, as airport detectors may pick up radiation for weeks

11. Questions to ask your care team

  • Do I really need radioactive iodine, given my risk group?
  • What dose will I have, and why?
  • Will I have TSH injections or stop my tablets?
  • What should I eat on the low-iodine diet?
  • How long must I follow radiation precautions?
  • How will this affect plans for pregnancy or fathering a child?
  • What follow-up tests will I need?

Resources

  1. Boucai, L., Zafereo, M. and Cabanillas, M.E. (2024) ‘Thyroid cancer: a review’, JAMA, 331(5), pp. 425-435.
  2. Ciarallo, A. and Rivera, J. (2020) ‘Radioactive iodine therapy in differentiated thyroid cancer: 2020 update’, American Journal of Roentgenology, 215(2), pp. 285-291.
  3. Leboulleux, S. et al. (2025) ‘Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial’, The Lancet Diabetes and Endocrinology, 13(1), pp. 38-46.
  4. Schlumberger, M. et al. (2018) ‘Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial’, The Lancet Diabetes and Endocrinology, 6(8), pp. 618-626.
  5. National Cancer Institute (2026) Thyroid Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.